Who
Kevin Sidow
Director
Company insider
Files Form 4 as: Director, Carlsmed; Director, Bioform Medical.
In numbers
- Trades disclosed
- 19
- Buys
- 1
- Sells
- 0
- Bought
- $200K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 12 Dec 2008
- Last trade
- 3 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Jul 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 22 Jun 2026 | CARL CarlsmedMedical Devices | SEC FORM 4 Code A | —13,698 at $0.00 | filing |
| 3 Jun 2026filed 22 Jun 2026 | CARL CarlsmedMedical Devices | SEC FORM 4 Code A | —13,698 at $0.00 | filing |
| 24 Jul 2025filed 24 Jul 2025 | CARL Carlsmedoption or derivative · Medical Devices | SEC FORM 4 Code C | —28,900 | filing |
| 24 Jul 2025filed 24 Jul 2025 | CARL CarlsmedMedical Devices | SEC FORM 4 Code M | —28,900 | filing |
| 24 Jul 2025filed 24 Jul 2025 | CARL CarlsmedMedical Devices | SEC FORM 4 Bought | $200K13,333 at $15.00 | filing |
| 22 Jul 2025filed 24 Jul 2025 | CARL CarlsmedMedical Devices | SEC FORM 4 Code A | —17,333 at $0.00 | filing |
| 16 Feb 2010filed 19 Feb 2010 | Bioform Medicaloption or derivative | SEC FORM 4 Code D | —10,000 at $0.00 | filing |
| 16 Feb 2010filed 19 Feb 2010 | Bioform Medicaloption or derivative | SEC FORM 4 Code D | —4,543 at $0.00 | filing |
| 16 Feb 2010filed 19 Feb 2010 | Bioform Medicaloption or derivative | SEC FORM 4 Code D | —8,053 at $0.00 | filing |
| 16 Feb 2010filed 19 Feb 2010 | Bioform Medicaloption or derivative | SEC FORM 4 Code D | —11,313 at $0.00 | filing |
| 16 Feb 2010filed 19 Feb 2010 | Bioform Medicaloption or derivative | SEC FORM 4 Code D | —14,729 at $0.00 | filing |
| 16 Feb 2010filed 19 Feb 2010 | Bioform Medicaloption or derivative | SEC FORM 4 Code D | —10,000 at $0.00 | filing |
| 16 Feb 2010filed 19 Feb 2010 | Bioform Medicaloption or derivative | SEC FORM 4 Code D | —35,000 at $0.00 | filing |
| 10 Dec 2009filed 29 Dec 2009 | Bioform Medicaloption or derivative | SEC FORM 4 Code A | $36K10,000 at $3.61 | filing |
| 1 Oct 2009filed 5 Oct 2009 | Bioform Medicaloption or derivative | SEC FORM 4 Code A | $16K4,543 at $3.62 | filing |
| 1 Jul 2009filed 6 Jul 2009 | Bioform Medicaloption or derivative | SEC FORM 4 Code A | $17K8,053 at $2.06 | filing |
| 1 Apr 2009filed 2 Apr 2009 | Bioform Medicaloption or derivative | SEC FORM 4 Code A | $14K11,313 at $1.20 | filing |
| 2 Jan 2009filed 6 Jan 2009 | Bioform Medicaloption or derivative | SEC FORM 4 Code A | $15K14,729 at $1.03 | filing |
| 12 Dec 2008filed 16 Dec 2008 | Bioform Medicaloption or derivative | SEC FORM 4 Code A | $11K10,000 at $1.10 | filing |
News
Comparing Carlsmed (NASDAQ:CARL) and Establishment Labs (NASDAQ:ESTA)CARL · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Kevin Sidow; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.